Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L L Gustafsson

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 18, 2007
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural TanzaniaJ Eriksen, S Mwankusye, S Mduma, et al.
Clinical Pharmacology and Therapeutics|August 1, 1995
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteersP Hartvig, J Valtysson, K J Lindner, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 19, 2017
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhoodL Forsberg, M Adler, I Römer Ek, et al.
HIV Medicine|November 24, 2011
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected UgandansS Nanzigu, J Eriksen, F Makumbi, et al.
Pharmacogenetics|January 14, 2000
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotypeA Wennerholm, I Johansson, A Y Massele, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavirF Josephson, A Allqvist, M Janabi, et al.
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services|October 16, 2004
Physicians' perceptions of possibilities and obstacles prior to implementing a computerised drug prescribing support systemP Bastholm Rahmner, E Andersén-Karlsson, T Arnhjort, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotypeK Herrlin, A Y Massele, M Jande, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 18, 2007
Antimalarial resistance and DHFR/DHPS genotypes of Plasmodium falciparum three years after introduction of sulfadoxine-pyrimethamine and amodiaquine in rural TanzaniaJ Eriksen, S Mwankusye, S Mduma, et al.
Clinical Pharmacology and Therapeutics|August 1, 1995
Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteersP Hartvig, J Valtysson, K J Lindner, et al.
Acta Paediatrica (Oslo, Norway : 1992)|November 19, 2017
Maternal mood disorders and lithium exposure in utero were not associated with poor cognitive development during childhoodL Forsberg, M Adler, I Römer Ek, et al.
HIV Medicine|November 24, 2011
Pharmacokinetics of the nonnucleoside reverse transcriptase inhibitor efavirenz among HIV-infected UgandansS Nanzigu, J Eriksen, F Makumbi, et al.
Pharmacogenetics|January 14, 2000
Decreased capacity for debrisoquine metabolism among black Tanzanians: analyses of the CYP2D6 genotype and phenotypeA Wennerholm, I Johansson, A Y Massele, et al.
Clinical Pharmacology and Therapeutics|March 3, 2007
CYP3A5 genotype has an impact on the metabolism of the HIV protease inhibitor saquinavirF Josephson, A Allqvist, M Janabi, et al.
International Journal of Health Care Quality Assurance Incorporating Leadership in Health Services|October 16, 2004
Physicians' perceptions of possibilities and obstacles prior to implementing a computerised drug prescribing support systemP Bastholm Rahmner, E Andersén-Karlsson, T Arnhjort, et al.
Clinical Pharmacology and Therapeutics|November 3, 1998
Bantu Tanzanians have a decreased capacity to metabolize omeprazole and mephenytoin in relation to their CYP2C19 genotypeK Herrlin, A Y Massele, M Jande, et al.
Pageof 10